Subscribe To
BIO / Bio-Rad (BIO) Core Diagnostic Sales Grow Amid Supply Challenges
BIO News
By Zacks Investment Research
October 27, 2023
Bio-Rad (BIO) Misses Q3 Earnings Estimates, Cuts 2023 View
The deterioration in biopharma and early biotech customer spending and a challenging macroeconomic environment in China impact Bio-Rad's (BIO) Q3 perf more_horizontal
By Seeking Alpha
October 26, 2023
Bio-Rad Laboratories, Inc. (BIO) Q3 2023 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO ) Q3 2023 Results Conference Call October 26, 2023 5:00 PM ET Company Participants Edward Chung - Head, IR Norman more_horizontal
By Zacks Investment Research
October 20, 2023
Bio-Rad Laboratories (BIO) to Post Q3 Earnings: What Awaits?
Bio-Rad (BIO) Life Science segment will likely have witnessed growth in Q3, driven by Droplet Digital PCR and qPCR products. more_horizontal
By Zacks Investment Research
September 19, 2023
New Strong Sell Stocks for September 19th
BIO, LPG and COLB have been added to the Zacks Rank #5 (Strong Sell) List on September 19, 2023. more_horizontal
By InvestorPlace
September 2, 2023
3 Beaten-Down Biotech Stocks Bound for a Bounce Back
Biotech stocks soared high during the COVID-19 pandemic, as they were our only hope for new drugs and vaccines to fight the virus. However, the biotec more_horizontal
By Zacks Investment Research
August 18, 2023
New Strong Sell Stocks for August 18th
BIO, REFI and GPK have been added to the Zacks Rank #5 (Strong Sell) List on August 18, 2023. more_horizontal
By Zacks Investment Research
August 4, 2023
Bio-Rad (BIO) Beats on Q2 Earnings Estimates, Cuts 2023 View
Growth across the Life Science portfolio and strong double-digit growth for ddPCR drive Bio-Rad (BIO) Q2 performance. more_horizontal
By Seeking Alpha
August 3, 2023
Bio-Rad Laboratories, Inc. (BIO) Q2 2023 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO ) Q2 2023 Earnings Conference Call August 3, 2023 5:00 PM ET Company Participants Edward Chung - Head, Investor R more_horizontal